|

Empagliflozin 10 mg daily dosing Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Jardiance 10 mg daily dosing

Pipeline

Phase 1/2: 1

Top Sponsors

  • University of Mississippi Medical Center1

Indications

  • Kidney Failure, Chronic1
  • Heart Disease1
  • Heart Failure1

Jackson, Mississippi1 trial

Empagliflozin in ESKD - A Feasibility Study

University of Mississippi Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.